Skip to content
Medical Health Aged Care, Seniors Interest

Australian aged care residents seven times more likely to be taking painkiller medications when compared with Japan

Monash University 2 mins read

A new study from Monash University, in collaboration with Japan’s Institute for Health Economics and Policy, has revealed that only 11 per cent of Japanese aged care facility residents are prescribed regular painkiller medications, compared to nearly three-quarters (74 per cent) of Australia’s aged care facility population.  

Furthermore, the use of opioid painkiller medicines in aged care facilities was found to be 30-fold higher in Australia.

The study, published in the medical journal Age and Ageing and led by Monash’s Centre for Medicine Use and Safety (CMUS) within the Monash Institute of Pharmaceutical Sciences (MIPS), compared painkiller use among two samples of Australian and Japanese residents with the goal to better understand the pharmacological management of pain in residential aged care.

The painkiller medicines in most regular use include oral acetaminophen (paracetamol), non-steroidal anti-inflammatory drugs (e.g. ibuprofen), or opioids.

Qualitative data obtained through focus groups with Australian and Japanese health care professionals highlighted the differences in therapeutic goals, painkiller regulations and treatment durations between the two countries.

The study’s lead author Ms Laura Dowd, a pharmacist and CMUS PhD candidate, said these differences may explain the disparities in painkiller use between the respective countries.

“Australian participants described their therapeutic goal was to alleviate pain and reported painkillers were often prescribed on a regular basis, whilst Japanese participants described their therapeutic goal was to minimise impacts of pain on daily activities and reported opioid painkillers were prescribed for short-term durations, corresponding to episodes of pain,” Ms Dowd said.

“Australia and Japan both have rapidly ageing populations but appear to have very different patterns of painkiller use. Understanding these differences can inform new initiatives to improve pain management.”

Senior author and CMUS Research Fellow Dr Amanda Cross said, “This study confirms previous CMUS research that shows up to one-third of Australian residents are prescribed opioid painkiller medicines and highlights key areas where on-site aged care pharmacists could work to support the appropriate use of opioids.”

Dr Shota Hamada from the Institute for Health Economics and Policy in Tokyo said, “Painkillers are one component of an effective pain management strategy. Understanding the different role of painkillers as part of the overall approach to pain management will help the safe and effective painkiller use.”

To read the full study visit https://academic.oup.com/ageing/article/53/2/afae024/7614404 

https://doi.org/10.1093/ageing/afae024 

ENDS


Contact details:

Kate Carthew, Media and Communications Manager, Monash University.

kate.carthew@monash.edu 

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 06/09/2024
  • 15:19
La Trobe University

Breakthrough in the hunt for broad-spectrum malaria therapy

Scientists at La Trobe University have discovered a new antibody-like molecule which could be used in therapy to prevent infection from multiple malaria parasite species. The research, recently published in Nature Communications, found that when the molecule WD34 binds with a protein produced by malaria parasites, it inhibits their ability to infect cells at different stages of the disease. Led by Professor Michael Foley, Professor Robin Anders and PhD candidate Dimuthu Angage at the La Trobe Institute for Molecular Science (LIMS), the research also showed that WD34 can protect against several different malaria parasite species. Professor Foley said the discovery…

  • Medical Health Aged Care
  • 06/09/2024
  • 10:16
Royal Australian College of GPs

NSW Government’s expanded role for pharmacy is reckless and unsafe for patients: RACGP

The New South Wales Government’s move to expand the scope of pharmacists to treat a range of conditions is politically driven and risks the health of people across the state, says the Royal Australian College of GPs. Health Minister Ryan Park made the announcement at a Pharmacy Guild conference last night that work was underway to expand pharmacists' scope to treat ear infections, wound management, nausea, gastro-oesophageal reflux disease, acne, and muscle and joint pain. RACGP NSW Chair Dr Rebekah Hoffman slammed the move as reckless and putting politics before patient safety. “This is politically driven policy, and it has…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 06/09/2024
  • 05:00
Lloyds Auctioneers and Valuers

Bid for a Cause: Whisky Auction Supports Brain Cancer Fight

After Jack was diagnosed with Glioblastoma Multiforme (GBM), one of the most aggressive and deadly brain cancers, he was given just 12 months to…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.